News

Progenics has decided to implement Rave integrated with United BioSource Corp’s (UBC) interactive voice response system (IVRS) to manage a Phase III study evaluating methylnaltrexone, an opioid-induced constipation

Net profit was up by 30% to INR1708m from INR1319m last year. During the quarter, Zydus Cadila’s revenues were driven by 35% growth in the global formulations business,

Topical Interferon Alpha-2b incorporates Helix BioPharma’s proprietary Biphasix drug delivery technology, designed to offer a superior means of delivering interferon-alpha-2b therapeutically to HPV-infected tissues. Helix BioPharma said that

Aastrom intends to initiate Phase 3 clinical testing of its treatment for CLI in early 2011. Aastrom said that the designation may allow it to submit portions of

Altomari, a former senior manager at Johnson & Johnson, has been serving as Agile’s executive chairman. He will succeed Thomas Rossi, who joined Agile as president and CEO

Diamyd claims that NP2 Enkephalin is the first drug candidate from its proprietary NTDDS (Nerve Targeting Drug Delivery System)platform focally delivering therapeutic compounds directly to the nervous system.

Synairgen said that upon issuance, the patented claims will provide the company with patent protection for the use of its drug in the elderly population. Synairgen CEO Richard

Furthermore, Health Canada has advised that an inspection for the issue of an Establishment License has been scheduled over a number of days commencing 29 November 2010, following

PillCam Express is a video capsule delivery device for patients who are unable to ingest the capsule or who have slow gastric emptying times PillCam SB 2-EX is